dactinomycin has been researched along with candesartan in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hibi, K; Ishigami, T; Ishii, M; Kihara, M; Kobayashi, I; Nyui, N; Sumida, Y; Takagi, N; Tamura, K; Umemura, S; Watanabe, Y; Yabana, M | 1 |
Hibi, K; Ishigami, T; Ishii, M; Kihara, M; Nyui, N; Tamura, K; Toya, Y; Umemura, S | 1 |
1 review(s) available for dactinomycin and candesartan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for dactinomycin and candesartan
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Regulation of cardiac angiotensinogen mRNA in vivo and in vitro.
Topics: Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Dactinomycin; Hypertension; Myocardium; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Inbred SHR; Rats, Wistar; RNA, Messenger; Stress, Mechanical; Tetrazoles; Transcription, Genetic; Up-Regulation | 1997 |
Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Animals, Newborn; Benzimidazoles; beta-Galactosidase; Biphenyl Compounds; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Cycloheximide; Dactinomycin; Gene Expression Regulation; Heart; Heart Ventricles; Imidazoles; Liver; Lung; Myocardium; Promoter Regions, Genetic; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Recombinant Fusion Proteins; RNA, Messenger; RNA, Ribosomal, 18S; Stress, Mechanical; Tetrazoles; Transcription, Genetic; Transfection | 1998 |